{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:07:20Z","timestamp":1791612440981,"version":"4.3.4"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jdcr.2021.07.027","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T12:17:00Z","timestamp":1628165820000},"page":"107-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Semaglutide-associated bullous pemphigoid"],"prefix":"10.1016","volume":"15","author":[{"given":"Clayton P.","family":"Burruss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti B.","family":"Burruss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdcr.2021.07.027_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archderm.138.3.385","article-title":"A systematic review of treatments for bullous pemphigoid","volume":"138","author":"Khumalo","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jdcr.2021.07.027_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"10.1016\/j.jdcr.2021.07.027_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12902-021-00689-7","article-title":"The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study","volume":"21","author":"Lambadiari","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"10.1016\/j.jdcr.2021.07.027_bib4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/ggi.13799","article-title":"Dulaglutide-related bullous pemphigoid in a patient with type\u20092 diabetes: a case report","volume":"19","author":"Fukuda","year":"2019","journal-title":"Geriatr Gerontol Int"},{"issue":"2","key":"10.1016\/j.jdcr.2021.07.027_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2230.2007.02603.x","article-title":"A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy","volume":"33","author":"Saraceno","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdcr.2021.07.027_bib6","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3389\/fimmu.2019.01238","article-title":"Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid","volume":"10","author":"Tasanen","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jdcr.2021.07.027_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2340\/00015555-0819","article-title":"Serological studies in bullous pemphigoid: a literature review of antibody titers at presentation and in clinical remission","volume":"90","author":"Leuci","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.jdcr.2021.07.027_bib8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jid.2017.12.035","article-title":"Vancomycin mediates IgA autoreactivity in drug-induced linear IgA bullous dermatosis","volume":"138","author":"Yamagami","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2021.07.027_bib9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jdv.12366","article-title":"Drug-induced pemphigoid: a review of the literature","volume":"28","author":"Stavropoulos","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262100518X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262100518X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:54Z","timestamp":1762474974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262100518X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":9,"alternative-id":["S235251262100518X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.07.027","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide-associated bullous pemphigoid","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}